Skip to Main Content

National Coverage Analysis (NCA) for Abarelix for the Treatment of Prostate Cancer (CAG-00238N)

Expand/collapse the Contacts section

Contact(s)

Kate Tillman

katherine.tillman@cms.hhs.gov

410-786-9252

Back to Top

Expand/collapse the Documents section

Documents

Tracking Sheet

Proposed Decision Memo

Decision Memo

View Public Comments

NCD for Abarelix for the Treatment of Prostate Cancer (110.19)

Back to Top

Expand/collapse the History of Considerations section

History of Considerations

Original Consideration for Abarelix for the Treatment of Prostate Cancer (this document)

Back to Top

Footer Links

www